4.3 Article

Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers

Journal

REGENERATIVE MEDICINE
Volume 11, Issue 3, Pages 245-260

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/rme-2015-0045

Keywords

angiogenesis; collagen I; diabetic ulcer; extracellular matrix proteins; laminin; mesenchymal stem cells; tissue engineering; tissue scaffolds; VEGF

Funding

  1. Yale-UCL Medtech Initiative Flagship Project Vascular Engineering award
  2. NIH [R56-HL095498, R01-HL-095498]
  3. Yale Department of Surgery Ohse award
  4. BBSRC [BB/F023774/1] Funding Source: UKRI
  5. Biotechnology and Biological Sciences Research Council [BB/F023774/1] Funding Source: researchfish

Ask authors/readers for more resources

Aim: We hypothesized that delivery of mesenchymal stem cells (MSCs) in a biomimetic collagen scaffold improves wound healing in a diabetic mouse model. Materials & methods: Rolled collagen scaffolds containing MSCs were implanted or applied topically to diabetic C57BL/6 mice with excisional wounds. Results: Rolled scaffolds were hypoxic, inducing MSC synthesis and secretion of VEGF. Diabetic mice with wounds treated with rolled scaffolds containing MSCs showed increased healing compared with controls. Histologic examination showed increased cellular proliferation, increased VEGF expression and capillary density, and increased numbers of macrophages, fibroblasts and smooth muscle cells. Addition of laminin to the collagen scaffold enhanced these effects. Conclusion: Activated MSCs delivered in a biomimetic-collagen scaffold enhanced wound healing in a translationally relevant diabetic mouse model.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available